MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Early-Onset Parkinson’s Disease in Active-Duty Service Members

    V. Nguyen, J. Jacobson, C. Hernandez-Zegada, M. Salas, W. Hoffman (San Antonio, USA)

    Objective: To provide insight into the population-specific vulnerabilities of United States military service members diagnosed with Early-onset Parkinson’s Disease Background: Early-onset Parkinson’s disease (EOPD) accounts…
  • 2025 International Congress

    A multi-center, randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson’s disease (DATSZ-PD study)

    M. Takahashi, J. Koh, T. Shimokawa, Y. Kajimoto, T. Takeshima, H. Ito (Hirakata, Osaka, Japan)

    Objective: To investigate the efficacy and safety for neuroprotection and disease modifying effect in  selegiline(SL) or zonisamide(ZN) by using UPDRS, PDQ-39 and DAT -SPECT  in…
  • 2025 International Congress

    Prevalence and Clinical Characteristics of Parkinson’s disease in Rural Nepal: A Community-Based Cross-Sectional Study

    A. Chandra, A. Chandra, S. Acharya (Kathmandu, Nepal)

    Objective: This study aims to determine the prevalence of PD in rural Nepal and characterize its clinical features in an effort to bridge the gap…
  • 2025 International Congress

    The Impact of Freezing of Gait on Falls over time in Parkinson’s disease

    A. Madamangalam, V. Lavu, J. Yu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesville, USA)

    Objective: To quantify falls related to Freezing of Gait (FoG) versus unrelated to FoG as Parkinson’s disease progresses. Background: FoG is a debilitating symptom of…
  • 2025 International Congress

    Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

    M. Zhong, J. Liu, Y. Li (shanghai, China)

    Objective: This study aims to investigate the causal relationship between disruptions in sleep circadian rhythms and the risk of seven brain disorders. Background: Disruptions in…
  • 2025 International Congress

    Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease

    Y. Matuk Perez, E. Fernandez Calleja, D. Resendiz Gonzalez, JM. Esquivias Farías, S. Alcauter Solórzano, I. Zamorano-Rangel (Queretaro, Mexico)

    Objective: This study aims to examine the relationship between hippocampal volume, assessed through magnetic resonance imaging (MRI), and MoCA test scores in patients diagnosed with…
  • 2025 International Congress

    The Impact of Socioeconomic Status on Functionality in people with Parkinson’s Disease

    A. Paixão, N. Pereira, R. Luz, E. Oliveira, I. Chaves, G. Vanucci, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the impact of socioeconomic status (SES) on functionality in people with Parkinson's disease (PD) using the World Health Organization Disability Assessment Schedule…
  • 2025 International Congress

    Preserved neuroplasticity in patients affected by Parkinson’s disease responders to auditory cueing strategies

    L. Avanzino, A. Botta, V. Romano, J. Nonnekes, M. Gilat, I. Maidan, E. Pelosin (Genoa, Italy)

    Objective: To study LTP-like plasticity in M1 in Parkinson’s disease (PD) patients affected responders to external auditory cueing strategies. Background: Neural plasticity in the primary…
  • 2025 International Congress

    A Study Of Axial Postural Abnormality In Parkinson`s

    V. Rama Raju (Hyderabad, India)

    Objective: APA involves distinct modes plus sequence patterns and proven predictors for every APA remains mystery. The goal is to probe the progress of APA…
  • 2025 International Congress

    Establishing a Timeline of Non-Motor and Motor Symptoms Progression in Parkinson’s Disease Using a Sub-Chronic MPTP Mouse Model

    M. Chopra, A. Sekar, R. Hussain, L. Diwakar (Bengaluru, India)

    Objective: Parkinson’s disease (PD) mouse model using 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was explored for pathological mechanisms driving non-motor symptoms (NMS). Aim was to map the behavioural changes…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley